AbbVie, J&J to add proprietary data to AI protein model in bid to accelerate drug discovery
Posted:
Life sciences data company Apheris on Thursday announced an effort to boost the capabilities of protein AI models by uniting several pharmaceutical companies’ proprietary data. Apheris’ consortium of pharma companies is partnering with OpenFold3 — Columbia professor Mohammed AlQuraishi’s open-source dupe of AlphaFold3 — to train the model on AbbVie and Johnson & Johnson’s vast stores of structural data. The collaboration will focus on structures relevant to drug discovery, such as small molecule-protein and antibody-antigen interactions.
From AI-powered healthcare platforms to virtual hospitals, Abto Software is advancing the future of digital health
Healthcare is undergoing a rapid transformation, with technology playing a vital role in improving access to care, supporting clinicians, and enabling more personalised patient…
Healthcare systems around the world are undergoing a fundamental transformation. As demand for care increases and health challenges become more complex, organisations are looking for new ways to connect information, improve collaboration and support better outcomes for both patients and…
Attendees
Sponsors and Exhibitors
Contact us